Design of MHC class II (DR4) ligands using conformationally restricted imino acids at p3 and p5

被引:22
作者
Hanson, GJ [1 ]
Vuletich, JL [1 ]
Bedell, LJ [1 ]
Bono, CP [1 ]
Howard, SC [1 ]
Welply, JK [1 ]
Woulfe, SL [1 ]
Zacheis, ML [1 ]
机构
[1] SEARLE RES,CHESTERFIELD,MO 63198
关键词
D O I
10.1016/0960-894X(96)00348-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
High potency synthetic ligands were designed for rheumatoid arthritis linked Class II MHC, DR4 Dw4. The design strategy utilized isosteric replacements at the p1 and p7 positions and conformational restriction with imino acids pipecolic acid (Pec) and proline at the solvent exposed residues p3 and p5. In particular, SC-67655, (S)-CBA-Val-Pec-Asp-Pro-Thr-NH-n-Pr (IC50 = 50 nM) is a potent and stable pentapeptide DR4 ligand. Copyright (C) 1996 Elsevier Science Ltd
引用
收藏
页码:1931 / 1936
页数:6
相关论文
共 10 条
[1]   HIGH-AFFINITY BINDING OF SHORT PEPTIDES TO MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES BY ANCHOR COMBINATIONS [J].
HAMMER, J ;
BELUNIS, C ;
BOLIN, D ;
PAPADOPOULOS, J ;
WALSKY, R ;
HIGELIN, J ;
DANHO, W ;
SINIGAGLIA, F ;
NAGY, ZA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4456-4460
[2]   PEPTIDE BINDING-SPECIFICITY OF HLA-DR4 MOLECULES - CORRELATION WITH RHEUMATOID-ARTHRITIS ASSOCIATION [J].
HAMMER, J ;
GALLAZZI, F ;
BONO, E ;
KARR, RW ;
GUENOT, J ;
VALSASNINI, P ;
NAGY, ZA ;
SINIGAGLIA, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1847-1855
[3]  
Hanson G J, 1994, Bioorg Med Chem, V2, P909, DOI 10.1016/S0968-0896(00)82040-4
[4]  
KIRSCHMANN DA, 1995, J IMMUNOL, V155, P5655
[5]  
NAGY ZA, 1995, ANNU REP MED CHEM, V30, P199
[6]   DESIGN AND SYNTHESIS OF PEPTIDOMIMETIC INHIBITORS OF HIV-1 PROTEASE AND RENIN - EVIDENCE FOR IMPROVED TRANSPORT [J].
SMITH, AB ;
HIRSCHMANN, R ;
PASTERNAK, A ;
AKAISHI, R ;
GUZMAN, MC ;
JONES, DR ;
KEENAN, TP ;
SPRENGELER, PA ;
DARKE, PL ;
EMINI, EA ;
HOLLOWAY, MK ;
SCHLEIF, WA .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (02) :215-218
[7]   CRYSTAL-STRUCTURE OF THE HUMAN CLASS-II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA-VIRUS PEPTIDE [J].
STERN, LJ ;
BROWN, JH ;
JARDETZKY, TS ;
GORGA, JC ;
URBAN, RG ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1994, 368 (6468) :215-221
[8]   THE MOLECULAR-BASIS OF SUSCEPTIBILITY TO RHEUMATOID-ARTHRITIS [J].
WINCHESTER, R .
ADVANCES IN IMMUNOLOGY, VOLUME 56, 1994, 56 :389-466
[9]   Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB1*0401 [J].
Woulfe, SL ;
Bono, CP ;
Zacheis, ML ;
Kirschmann, DA ;
Baudino, TA ;
Swearingen, C ;
Karr, RW ;
Schwartz, BD .
ARTHRITIS AND RHEUMATISM, 1995, 38 (12) :1744-1753
[10]  
WOULFE SL, UNPUB